Paliperidone
44 NDCs across 13 manufacturers|41 Generic,3 Brand
Paliperidone is used to treat bipolar disorder, depressive disorder and schizophrenia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 19, 2006, and the first generic was approved Aug 3, 2015. FDA's Orange Book lists 46 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $81 million on Paliperidone across 397,000 claims for 53,000 beneficiaries.
Paliperidone is available as 44 NDCs from 13 manufacturers (41 generic, 3 brand), with NADAC prices from $0.82 to $18.64 per EA — the most expensive product costs about 23× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
44
41G / 3B
Manufacturers
13
competing in market
Price Spread
$0.82 – $18.64
per EA
7d Activity
avg +5.9% WoW · of 44 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
NorthStar Rx LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Atypical Antipsychotic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
13 manufacturers producing PALIPERIDONE(2 pricing outliers)
Frequently Asked Questions
What is Paliperidone used to treat?
Paliperidone is used to treat bipolar disorder, depressive disorder and schizophrenia, per the National Library of Medicine's MED-RT classification.
When did Paliperidone become available as a generic?
FDA approved the first generic Paliperidone (ANDA) on Aug 3, 2015. The Orange Book currently lists 46 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Paliperidone?
In 2024, Medicare Part D spent $81 million on Paliperidone across 397,000 claims for 53,000 beneficiaries.
How many Paliperidone products are on the market?
The Paliperidone drug market contains 44 NDCs from 13 manufacturers — 41 generic and 3 brand products.
What is the price range for Paliperidone?
NADAC reference prices for Paliperidone range from $0.8204 to $18.6412 per EA — the most expensive product costs about 23× the cheapest.
Is generic Paliperidone cheaper than brand?
The average generic NADAC for Paliperidone is $0.9914 per EA, versus $14.4810 for brand-labeled products — brand versions average about 15× the generic price.
Which manufacturers make Paliperidone?
13 manufacturers list Paliperidone in NADAC. Ranked by number of NDCs, the largest are NorthStar Rx LLC (4), Camber Pharmaceuticals Inc. (4), Westminster Pharmaceuticals LLC (4), Tris Pharma Inc (4), Amneal Pharmaceuticals LLC (4).
How has the price of Paliperidone changed recently?
Over the past 7 days, 41 Paliperidone NDCs rose and 1 fell, with a market-wide average change of +5.9%.